Novartis AG vs Linde plc
Vergleich der Marktkapitalisierung im Zeitverlauf
Novartis AG
$244.1B
Rang #67
Linde plc
$252.7B
Rang #64
Marktkapitalisierung im Zeitverlauf
Wichtige Momente
- Linde plc überholte Novartis AG bis 2021
- Novartis AG überholte Linde plc bis 2022
- Linde plc überholte Novartis AG bis 2023
- Novartis AG überholte Linde plc bis 2025
- Linde plc überholte Novartis AG bis 2026
Vergleich Jahr für Jahr
| Jahr | Novartis AG | Linde plc | Spitzenreiter |
|---|---|---|---|
| 2026 | $244.1B | $252.7B | Linde plc |
| 2025 | $227.3B | $195.1B | Novartis AG |
| 2024 | $177.6B | $189.2B | Linde plc |
| 2023 | $163.8B | $183.3B | Linde plc |
| 2022 | $146.3B | $143.6B | Novartis AG |
| 2021 | $134.5B | $150.2B | Linde plc |
| 2020 | $134.7B | $112.5B | Novartis AG |
| 2019 | $142.4B | $89.4B | Novartis AG |
| 2018 | $110.8B | $64.2B | Novartis AG |
| 2017 | $104.0B | $62.3B | Novartis AG |
| 2016 | $89.6B | $46.1B | Novartis AG |
| 2015 | $100.4B | $39.2B | Novartis AG |
| 2014 | $103.4B | $48.4B | Novartis AG |
| 2013 | $76.6B | $47.7B | Novartis AG |
| 2012 | $59.2B | $39.3B | Novartis AG |
| 2011 | $52.5B | $37.6B | Novartis AG |
| 2010 | $51.1B | $32.9B | Novartis AG |
| 2009 | $50.7B | $27.1B | Novartis AG |
| 2008 | $44.5B | $19.5B | Novartis AG |
| 2007 | $50.6B | $28.7B | Novartis AG |
| 2006 | $55.9B | $18.9B | Novartis AG |
| 2005 | $53.9B | $16.6B | Novartis AG |
| 2004 | $43.8B | $13.6B | Novartis AG |
| 2003 | $42.0B | $11.6B | Novartis AG |
| 2002 | $36.9B | $8.6B | Novartis AG |
| 2001 | $43.1B | $8.2B | Novartis AG |
| 2000 | $50.7B | $6.5B | Novartis AG |
| 1999 | $40.7B | $7.2B | Novartis AG |
| 1998 | $46.3B | $5.0B | Novartis AG |
| 1997 | $40.1B | $6.3B | Novartis AG |
| 1996 | $24.5B | $6.4B | Novartis AG |
| 1995 | $16.9B | $4.6B | Novartis AG |